<code id='0DD65DCA26'></code><style id='0DD65DCA26'></style>
    • <acronym id='0DD65DCA26'></acronym>
      <center id='0DD65DCA26'><center id='0DD65DCA26'><tfoot id='0DD65DCA26'></tfoot></center><abbr id='0DD65DCA26'><dir id='0DD65DCA26'><tfoot id='0DD65DCA26'></tfoot><noframes id='0DD65DCA26'>

    • <optgroup id='0DD65DCA26'><strike id='0DD65DCA26'><sup id='0DD65DCA26'></sup></strike><code id='0DD65DCA26'></code></optgroup>
        1. <b id='0DD65DCA26'><label id='0DD65DCA26'><select id='0DD65DCA26'><dt id='0DD65DCA26'><span id='0DD65DCA26'></span></dt></select></label></b><u id='0DD65DCA26'></u>
          <i id='0DD65DCA26'><strike id='0DD65DCA26'><tt id='0DD65DCA26'><pre id='0DD65DCA26'></pre></tt></strike></i>

          explore

          explore

          author:fashion    Page View:7782
          Cathy McMorris Rodgers -- health policy coverage from STAT
          Rep. Cathy McMorris Rodgers (R-Wash.), chair of the House Energy and Commerce Committee. Anna Moneymaker/Getty Images

          WASHINGTON — House Republicans have drafted drug-shortage legislation that differs significantly from the approach Democrats propose to stem shortages of chemotherapies and other critical medicines that hospitals typically use.

          Republicans on the House Energy and Commerce Committee are focused on what they say are the underlying economic reasons for shortages. Hospitals band together to negotiate drug prices, and makers of generic injectables say those group purchasing organizations can drive prices down so low that they stop making certain drugs or can’t afford to maintain manufacturing facilities, which then leads to manufacturing interruptions.

          advertisement

          Rep. Frank Pallone (D-N.J.), the ranking Democrat on Energy and Commerce, called some of the Republican proposals “handouts” to drug companies and said they don’t fix the problem. Democrats also have been critical of Republicans’ choice to separate the drug shortage policies from a must-pass pandemic-preparedness bill — they’d rather combine the two efforts to increase its chances of success.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Roche’s Alnylam deal shows drug firms interested in heart drugs
          Roche’s Alnylam deal shows drug firms interested in heart drugs

          AdobeRoche’sannouncementMondaythatitwouldpay$310millionforrightstoahypertensiontreatment,zilebesiran

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          Judge rejects Trump's request to move Stormy Daniels hush

          0:31FormerPresidentDonaldTrumpspeaksattheConservativePoliticalActionConference,CPAC2023,March4,2023,